Chemed (CHE) Non Operating Interest Expenses (2009 - 2026)

Chemed has reported Non Operating Interest Expenses for 3 years, with the latest figure at $21.8 million in Q2 2026.

• Non Operating Interest Expenses for Q2 2026 came in at $21.8 million, up 15.05% year-over-year; the trailing twelve-month figure through Jun 2026 was $83.9 million (up 14.24% YoY), and the FY2025 annual result was $77.1 million, up 5.46% from the prior year.
• Non Operating Interest Expenses eased to $21.8 million in Q2 2026, from $22.0 million in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $22.0 million in Q1 2026 and troughed at $17.3 million in Q2 2024.
• A 3-year average of $19.4 million and a median of $19.2 million in 2024 frame the typical range for Non Operating Interest Expenses.
• The widest annual swing landed in 2025, when Non Operating Interest Expenses declined 6.94%; it then rose 21.31% in 2026.
• A 3-year view of Non Operating Interest Expenses shows it stood at $17.9 million in 2024, then advanced by 14.59% to $20.5 million in 2025, then climbed by 6.39% to $21.8 million in 2026.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $21.8 million in Q2 2026, $22.0 million in Q1 2026, and $20.5 million in Q4 2025.